SMC1A expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.69199999999758E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.587800E-04 |
Normal-vs-Stage2 |
2.37419999999933E-05 |
Normal-vs-Stage3 |
1.828360E-04 |
Normal-vs-Stage4 |
8.48300000000357E-05 |
Stage1-vs-Stage2 |
1.160820E-01 |
Stage1-vs-Stage3 |
2.548600E-01 |
Stage1-vs-Stage4 |
1.872390E-01 |
Stage2-vs-Stage3 |
6.403800E-01 |
Stage2-vs-Stage4 |
7.180600E-01 |
Stage3-vs-Stage4 |
9.145400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.52453999999747E-05 |
Normal-vs-AfricanAmerican |
4.26840000011808E-07 |
Normal-vs-Asian |
9.963000E-01 |
Caucasian-vs-AfricanAmerican |
3.708000E-02 |
Caucasian-vs-Asian |
2.197400E-01 |
AfricanAmerican-vs-Asian |
3.213900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.75129910573446E-11 |
Normal-vs-Female |
8.790800E-01 |
Male-vs-Female |
1.54098955817972E-13 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.0875999999932E-05 |
Normal-vs-Age(41-60Yrs) |
8.24530000000934E-05 |
Normal-vs-Age(61-80Yrs) |
3.78050000000574E-05 |
Normal-vs-Age(81-100Yrs) |
3.225900E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.233970E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.221400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.774400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.329200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.920800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.683000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.841800E-01 |
Normal-vs-Grade 2 |
6.762900E-04 |
Normal-vs-Grade 3 |
1.78760000002498E-06 |
Normal-vs-Grade 4 |
3.62419999999641E-06 |
Grade 1-vs-Grade 2 |
1.307360E-01 |
Grade 1-vs-Grade 3 |
5.363900E-02 |
Grade 1-vs-Grade 4 |
1.452180E-02 |
Grade 2-vs-Grade 3 |
7.502200E-02 |
Grade 2-vs-Grade 4 |
4.064200E-02 |
Grade 3-vs-Grade 4 |
5.510600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.956100E-02 |
Normal-vs-ccB subtype |
2.75270000005268E-06 |
ccA subtype-vs-ccB subtype |
3.038700E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.200400E-04 |
Normal-vs-N1 |
2.153400E-01 |
N0-vs-N1 |
9.901000E-01 |
|
|